BIOMAT Database Logo BIOMAT Database Logo

[A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen]. 1993

L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin

A new chemical typhoid vaccine containing the complex of surface Vi- and K-antigens has been obtained and experimentally studied. The vaccine has been found to possess high immunogenic and antigenic potency. Typhoid complex vaccine containing K-antigen stimulates the development of anti-infection and postvaccinal complex.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D012485 Salmonella typhi A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER. Salmonella enterica serovar Typhi,Salmonella typhosa
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
[Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
January 1973, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
[Purified soluble antigen of R. prowazekii (the chemical anti-typhoid vaccine)].
January 1969, Revue d'immunologie et de therapie antimicrobienne,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
Molecular characterization of pneumococcal surface protein K, a potential pneumococcal vaccine antigen.
August 2017, Virulence,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
Typhoid vaccine; Vi antigen and Vi antibody.
January 1957, Acta pathologica et microbiologica Scandinavica. Supplementum,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
Typhoid Vaccine Studies X-The Suitability of Vi Antigen as an Auxiliary Immunogen for Typhoid Vaccine.
January 1946, American journal of public health and the nation's health,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
Typhoid vaccine studies; the suitability of Vi antigen as an auxiliary immunogen for typhoid vaccine; progress report.
January 1946, American journal of public health and the nation's health,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
A Live Oral Fowl Typhoid Vaccine with Reversible O-Antigen Production.
March 2015, Avian diseases,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
Typhoid Vaccine Studies VII: Typhoid-Paratyphoid Vaccine.
May 1943, American journal of public health and the nation's health,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy.
November 2007, Expert opinion on biological therapy,
L K Stepanova, and Iu A Belaia, and N S Sergeeva, and V A Ageeva, and V G Petrukhin
[Immunological effectiveness of typhoid chemical vaccine in experimental enteral immunization].
February 1971, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!